Piper Jaffray Cuts Price Target on Derma Sciences (DSCI) Following Mixed 3Q Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- Wall St futures muted as investors monitor US-Iran negotiations
- Oil falls after US-Iran talks signal easing supply risks
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
- Sanuwave cuts Q2 2026 revenue guidance amid Ultramist sales pressure
Derma Sciences Reports Third Quarter 2015 Financial Results
November 9, 2015 7:30 AM ESTNet Sales Increase 10% and Advanced Wound Care Sales Increase 20%
Conference call begins at 10:00 a.m. Eastern time today
PRINCETON, N.J.--(BUSINESS WIRE)-- Derma Sciences, Inc. (Nasdaq: DSCI), a tissue regeneration company focused on advanced wound and burn care, today reported financial and operating results for the three and nine months ended September 30, 2015.
Financial highlights of the third quarter of 2015 include (all comparisons are with the third quarter of 2014):
Advanced Wound Care (AWC) net sales increased 19.8% to $11.3 million, or 21.0%... More